Global Hemophilia Gene Therapy Market Insights, Forecast to 2029

Publisher Name :
Date: 22-Sep-2023
No. of pages: 90
Inquire Before Buying

Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals with hemophilia experience bleeding episodes after injuries and spontaneous bleeding episodes that often lead to joint disease such as arthritis. The most frequent forms of hemophilia affect males.

Market Analysis and Insights: Global Hemophilia Gene Therapy Market

The global Hemophilia Gene Therapy market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

Global Hemophilia Gene Therapy key players include Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, etc.

Report Includes

This report presents an overview of global market for Hemophilia Gene Therapy market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Hemophilia Gene Therapy, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Hemophilia Gene Therapy, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Hemophilia Gene Therapy revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Hemophilia Gene Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Hemophilia Gene Therapy revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Spark Therapeutics, Ultragenyx, Shire PLC, Sangamo Therapeutics, Bioverativ, BioMarin, uniQure and Freeline Therapeutics, etc.

By Company

- Spark Therapeutics

- Ultragenyx

- Shire PLC

- Sangamo Therapeutics

- Bioverativ

- BioMarin

- uniQure

- Freeline Therapeutics

Segment by Type

- Hemophilia A

- Hemophilia B

Segment by Application

- Hemophilia A Gene Therapy

- Hemophilia B Gene Therapy

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East, Africa, and Latin America

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Chapter Outline

Chapter 1: Introduces the Report Scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of Hemophilia Gene Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hemophilia Gene Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: North America by type, by application and by country, revenue for each segment.

Chapter 7: Europe by type, by application and by country, revenue for each segment.

Chapter 8: China by type and by application revenue for each segment.

Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.

Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemophilia Gene Therapy revenue, gross margin, and recent development, etc.

Chapter 12: Analyst's Viewpoints/Conclusions

Global Hemophilia Gene Therapy Market Insights, Forecast to 2029

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hemophilia Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Hemophilia A
1.2.3 Hemophilia B
1.3 Market by Application
1.3.1 Global Hemophilia Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hemophilia A Gene Therapy
1.3.3 Hemophilia B Gene Therapy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hemophilia Gene Therapy Market Perspective (2018-2029)
2.2 Global Hemophilia Gene Therapy Growth Trends by Region
2.2.1 Hemophilia Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Hemophilia Gene Therapy Historic Market Size by Region (2018-2023)
2.2.3 Hemophilia Gene Therapy Forecasted Market Size by Region (2024-2029)
2.3 Hemophilia Gene Therapy Market Dynamics
2.3.1 Hemophilia Gene Therapy Industry Trends
2.3.2 Hemophilia Gene Therapy Market Drivers
2.3.3 Hemophilia Gene Therapy Market Challenges
2.3.4 Hemophilia Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Hemophilia Gene Therapy by Players
3.1.1 Global Hemophilia Gene Therapy Revenue by Players (2018-2023)
3.1.2 Global Hemophilia Gene Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Hemophilia Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Hemophilia Gene Therapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Hemophilia Gene Therapy Market Concentration Ratio
3.4.1 Global Hemophilia Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hemophilia Gene Therapy Revenue in 2022
3.5 Global Key Players of Hemophilia Gene Therapy Head office and Area Served
3.6 Global Key Players of Hemophilia Gene Therapy, Product and Application
3.7 Global Key Players of Hemophilia Gene Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Hemophilia Gene Therapy Breakdown Data by Type
4.1 Global Hemophilia Gene Therapy Historic Market Size by Type (2018-2023)
4.2 Global Hemophilia Gene Therapy Forecasted Market Size by Type (2024-2029)
5 Hemophilia Gene Therapy Breakdown Data by Application
5.1 Global Hemophilia Gene Therapy Historic Market Size by Application (2018-2023)
5.2 Global Hemophilia Gene Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Hemophilia Gene Therapy Market Size (2018-2029)
6.2 North America Hemophilia Gene Therapy Market Size by Type
6.2.1 North America Hemophilia Gene Therapy Market Size by Type (2018-2023)
6.2.2 North America Hemophilia Gene Therapy Market Size by Type (2024-2029)
6.2.3 North America Hemophilia Gene Therapy Market Share by Type (2018-2029)
6.3 North America Hemophilia Gene Therapy Market Size by Application
6.3.1 North America Hemophilia Gene Therapy Market Size by Application (2018-2023)
6.3.2 North America Hemophilia Gene Therapy Market Size by Application (2024-2029)
6.3.3 North America Hemophilia Gene Therapy Market Share by Application (2018-2029)
6.4 North America Hemophilia Gene Therapy Market Size by Country
6.4.1 North America Hemophilia Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Hemophilia Gene Therapy Market Size by Country (2018-2023)
6.4.3 North America Hemophilia Gene Therapy Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hemophilia Gene Therapy Market Size (2018-2029)
7.2 Europe Hemophilia Gene Therapy Market Size by Type
7.2.1 Europe Hemophilia Gene Therapy Market Size by Type (2018-2023)
7.2.2 Europe Hemophilia Gene Therapy Market Size by Type (2024-2029)
7.2.3 Europe Hemophilia Gene Therapy Market Share by Type (2018-2029)
7.3 Europe Hemophilia Gene Therapy Market Size by Application
7.3.1 Europe Hemophilia Gene Therapy Market Size by Application (2018-2023)
7.3.2 Europe Hemophilia Gene Therapy Market Size by Application (2024-2029)
7.3.3 Europe Hemophilia Gene Therapy Market Share by Application (2018-2029)
7.4 Europe Hemophilia Gene Therapy Market Size by Country
7.4.1 Europe Hemophilia Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Hemophilia Gene Therapy Market Size by Country (2018-2023)
7.4.3 Europe Hemophilia Gene Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Hemophilia Gene Therapy Market Size (2018-2029)
8.2 China Hemophilia Gene Therapy Market Size by Type
8.2.1 China Hemophilia Gene Therapy Market Size by Type (2018-2023)
8.2.2 China Hemophilia Gene Therapy Market Size by Type (2024-2029)
8.2.3 China Hemophilia Gene Therapy Market Share by Type (2018-2029)
8.3 China Hemophilia Gene Therapy Market Size by Application
8.3.1 China Hemophilia Gene Therapy Market Size by Application (2018-2023)
8.3.2 China Hemophilia Gene Therapy Market Size by Application (2024-2029)
8.3.3 China Hemophilia Gene Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Hemophilia Gene Therapy Market Size (2018-2029)
9.2 Asia Hemophilia Gene Therapy Market Size by Type
9.2.1 Asia Hemophilia Gene Therapy Market Size by Type (2018-2023)
9.2.2 Asia Hemophilia Gene Therapy Market Size by Type (2024-2029)
9.2.3 Asia Hemophilia Gene Therapy Market Share by Type (2018-2029)
9.3 Asia Hemophilia Gene Therapy Market Size by Application
9.3.1 Asia Hemophilia Gene Therapy Market Size by Application (2018-2023)
9.3.2 Asia Hemophilia Gene Therapy Market Size by Application (2024-2029)
9.3.3 Asia Hemophilia Gene Therapy Market Share by Application (2018-2029)
9.4 Asia Hemophilia Gene Therapy Market Size by Region
9.4.1 Asia Hemophilia Gene Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Hemophilia Gene Therapy Market Size by Region (2018-2023)
9.4.3 Asia Hemophilia Gene Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Spark Therapeutics
11.1.1 Spark Therapeutics Company Details
11.1.2 Spark Therapeutics Business Overview
11.1.3 Spark Therapeutics Hemophilia Gene Therapy Introduction
11.1.4 Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.1.5 Spark Therapeutics Recent Developments
11.2 Ultragenyx
11.2.1 Ultragenyx Company Details
11.2.2 Ultragenyx Business Overview
11.2.3 Ultragenyx Hemophilia Gene Therapy Introduction
11.2.4 Ultragenyx Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.2.5 Ultragenyx Recent Developments
11.3 Shire PLC
11.3.1 Shire PLC Company Details
11.3.2 Shire PLC Business Overview
11.3.3 Shire PLC Hemophilia Gene Therapy Introduction
11.3.4 Shire PLC Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.3.5 Shire PLC Recent Developments
11.4 Sangamo Therapeutics
11.4.1 Sangamo Therapeutics Company Details
11.4.2 Sangamo Therapeutics Business Overview
11.4.3 Sangamo Therapeutics Hemophilia Gene Therapy Introduction
11.4.4 Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.4.5 Sangamo Therapeutics Recent Developments
11.5 Bioverativ
11.5.1 Bioverativ Company Details
11.5.2 Bioverativ Business Overview
11.5.3 Bioverativ Hemophilia Gene Therapy Introduction
11.5.4 Bioverativ Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.5.5 Bioverativ Recent Developments
11.6 BioMarin
11.6.1 BioMarin Company Details
11.6.2 BioMarin Business Overview
11.6.3 BioMarin Hemophilia Gene Therapy Introduction
11.6.4 BioMarin Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.6.5 BioMarin Recent Developments
11.7 uniQure
11.7.1 uniQure Company Details
11.7.2 uniQure Business Overview
11.7.3 uniQure Hemophilia Gene Therapy Introduction
11.7.4 uniQure Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.7.5 uniQure Recent Developments
11.8 Freeline Therapeutics
11.8.1 Freeline Therapeutics Company Details
11.8.2 Freeline Therapeutics Business Overview
11.8.3 Freeline Therapeutics Hemophilia Gene Therapy Introduction
11.8.4 Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023)
11.8.5 Freeline Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Hemophilia Gene Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Hemophilia A
Table 3. Key Players of Hemophilia B
Table 4. Global Hemophilia Gene Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Hemophilia Gene Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Hemophilia Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Hemophilia Gene Therapy Market Share by Region (2018-2023)
Table 8. Global Hemophilia Gene Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Hemophilia Gene Therapy Market Share by Region (2024-2029)
Table 10. Hemophilia Gene Therapy Market Trends
Table 11. Hemophilia Gene Therapy Market Drivers
Table 12. Hemophilia Gene Therapy Market Challenges
Table 13. Hemophilia Gene Therapy Market Restraints
Table 14. Global Hemophilia Gene Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Hemophilia Gene Therapy Revenue Share by Players (2018-2023)
Table 16. Global Top Hemophilia Gene Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2022)
Table 17. Global Hemophilia Gene Therapy Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by Hemophilia Gene Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of Hemophilia Gene Therapy, Headquarters and Area Served
Table 20. Global Key Players of Hemophilia Gene Therapy, Product and Application
Table 21. Global Key Players of Hemophilia Gene Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Hemophilia Gene Therapy Revenue Market Share by Type (2018-2023)
Table 25. Global Hemophilia Gene Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Hemophilia Gene Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Hemophilia Gene Therapy Revenue Share by Application (2018-2023)
Table 29. Global Hemophilia Gene Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Hemophilia Gene Therapy Revenue Share by Application (2024-2029)
Table 31. North America Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America Hemophilia Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America Hemophilia Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Hemophilia Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Hemophilia Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America Hemophilia Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe Hemophilia Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe Hemophilia Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Hemophilia Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Hemophilia Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe Hemophilia Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 46. China Hemophilia Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 48. China Hemophilia Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia Hemophilia Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia Hemophilia Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Hemophilia Gene Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Hemophilia Gene Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia Hemophilia Gene Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Hemophilia Gene Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 63. Spark Therapeutics Company Details
Table 64. Spark Therapeutics Business Overview
Table 65. Spark Therapeutics Hemophilia Gene Therapy Product
Table 66. Spark Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 67. Spark Therapeutics Recent Developments
Table 68. Ultragenyx Company Details
Table 69. Ultragenyx Business Overview
Table 70. Ultragenyx Hemophilia Gene Therapy Product
Table 71. Ultragenyx Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 72. Ultragenyx Recent Developments
Table 73. Shire PLC Company Details
Table 74. Shire PLC Business Overview
Table 75. Shire PLC Hemophilia Gene Therapy Product
Table 76. Shire PLC Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 77. Shire PLC Recent Developments
Table 78. Sangamo Therapeutics Company Details
Table 79. Sangamo Therapeutics Business Overview
Table 80. Sangamo Therapeutics Hemophilia Gene Therapy Product
Table 81. Sangamo Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 82. Sangamo Therapeutics Recent Developments
Table 83. Bioverativ Company Details
Table 84. Bioverativ Business Overview
Table 85. Bioverativ Hemophilia Gene Therapy Product
Table 86. Bioverativ Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 87. Bioverativ Recent Developments
Table 88. BioMarin Company Details
Table 89. BioMarin Business Overview
Table 90. BioMarin Hemophilia Gene Therapy Product
Table 91. BioMarin Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 92. BioMarin Recent Developments
Table 93. uniQure Company Details
Table 94. uniQure Business Overview
Table 95. uniQure Hemophilia Gene Therapy Product
Table 96. uniQure Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 97. uniQure Recent Developments
Table 98. Freeline Therapeutics Company Details
Table 99. Freeline Therapeutics Business Overview
Table 100. Freeline Therapeutics Hemophilia Gene Therapy Product
Table 101. Freeline Therapeutics Revenue in Hemophilia Gene Therapy Business (2018-2023) & (US$ Million)
Table 102. Freeline Therapeutics Recent Developments
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hemophilia Gene Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Hemophilia Gene Therapy Market Share by Type: 2022 VS 2029
Figure 3. Hemophilia A Features
Figure 4. Hemophilia B Features
Figure 5. Global Hemophilia Gene Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Hemophilia Gene Therapy Market Share by Application: 2022 VS 2029
Figure 7. Hemophilia A Gene Therapy Case Studies
Figure 8. Hemophilia B Gene Therapy Case Studies
Figure 9. Hemophilia Gene Therapy Report Years Considered
Figure 10. Global Hemophilia Gene Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Hemophilia Gene Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Hemophilia Gene Therapy Market Share by Region: 2022 VS 2029
Figure 13. Global Hemophilia Gene Therapy Market Share by Players in 2022
Figure 14. Global Top Hemophilia Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Gene Therapy as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Hemophilia Gene Therapy Revenue in 2022
Figure 16. North America Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Hemophilia Gene Therapy Market Share by Type (2018-2029)
Figure 18. North America Hemophilia Gene Therapy Market Share by Application (2018-2029)
Figure 19. North America Hemophilia Gene Therapy Market Share by Country (2018-2029)
Figure 20. United States Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Hemophilia Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe Hemophilia Gene Therapy Market Share by Type (2018-2029)
Figure 24. Europe Hemophilia Gene Therapy Market Share by Application (2018-2029)
Figure 25. Europe Hemophilia Gene Therapy Market Share by Country (2018-2029)
Figure 26. Germany Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China Hemophilia Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China Hemophilia Gene Therapy Market Share by Type (2018-2029)
Figure 34. China Hemophilia Gene Therapy Market Share by Application (2018-2029)
Figure 35. Asia Hemophilia Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia Hemophilia Gene Therapy Market Share by Type (2018-2029)
Figure 37. Asia Hemophilia Gene Therapy Market Share by Application (2018-2029)
Figure 38. Asia Hemophilia Gene Therapy Market Share by Region (2018-2029)
Figure 39. Japan Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America Hemophilia Gene Therapy Market Share by Country (2018-2029)
Figure 49. Brazil Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries Hemophilia Gene Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Spark Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 56. Ultragenyx Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 57. Shire PLC Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 58. Sangamo Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 59. Bioverativ Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 60. BioMarin Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 61. uniQure Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 62. Freeline Therapeutics Revenue Growth Rate in Hemophilia Gene Therapy Business (2018-2023)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
  • Global Gene Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 111
    According to our LPI (LP Information) latest study, the global Gene Therapy market size was valued at US$ 6923.7 million in 2023. With growing demand in downstream market, the Gene Therapy is forecast to a readjusted size of US$ 40340 million by 2030 with a CAGR of 28.6% during review period. The research report highlights the growth potential of the global Gene Therapy market. Gene Therapy are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Hemophilia Gene Therapy Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Hemophilia Gene Therapy market size was valued at US$ million in 2023. With growing demand in downstream market, the Hemophilia Gene Therapy is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Hemophilia Gene Therapy market. Hemophilia Gene Therapy are expected to show stable growth in the future market. However, produc......
  • Global Cell and Gene Therapy CDMO Market (2024 Edition): Analysis By Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication, By Region, By Country: Market Insights and Forecast (2024-2029)
    Published: 01-Jan-2024        Price: US 2450 Onwards        Pages: 260
    Executive Summary Azoth Analytics has released a research report titled "Global Cell and Gene Therapy CDMO Market (2024 Edition)" which provides a complete analysis of the Global Cell and Gene Therapy CDMO Market industry in terms of market segmentation by Type (Cell Therapy, Gene Therapy, Gene-modified Cell Therapies), Application (Clinical, Pre-clinical), Indication (Oncology Diseases, Infectious Diseases, Neurological Disorder, Others) for the historical period of 2019-2022, es......
  • Global Hemophilia Gene Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 88
    According to our (Global Info Research) latest study, the global Hemophilia Gene Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Hemophilia is a rare bleeding disorder in which the blood does not clot normally. Hemophilia is a monogenic disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode pr......
  • Global Gene Expression Analysis Market Status and Outlook 2023-2028
    Published: 26-Dec-2023        Price: US 3160 Onwards        Pages: 102
    Gene expression analyses study the occurrence or activity of the formation of a gene product from its coding gene. It is a sensitive indicator of biological activity wherein a changing gene expression pattern is reflected in a change of biological process. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This ......
  • Global Gene Expression Analysis Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 26-Dec-2023        Price: US 3380 Onwards        Pages: 125
    Market Overview of Global Gene Expression Analysis market: According to our latest research, the global Gene Expression Analysis market looks promising in the next 5 years. As of 2022, the global Gene Expression Analysis market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
  • Global Animal Genetics Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 120
    Report Overview: Animal Genetics is a branch of genetics that studies heredity and variation chiefly in farm animals but also in domestic and wild animals. It is based on general genetic principles and concepts, and it mainly uses the hybrid, cytological, population, ontogenetic, mathematical-statistical, and twin methods of general genetics. Animal breeding or genetics is the area of science where experts are trying to steer the frequency of certain genes by combining the most super......
  • Global Animal Genetics Market Status and Outlook 2023-2028
    Published: 24-Nov-2023        Price: US 3160 Onwards        Pages: 105
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Gene Therapy Collaboration and Licensing Deals 2016-2023
    Published: 01-Nov-2023        Price: US 3995 Onwards        Pages: 450
    Gene Therapy Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the gene therapy deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of gene therapy deals from 2016 to 2023. The report provides a detailed understanding and analysis of how and why companies enter gene therapy deals. These deals tend to be multicomponent, starting with collaborative R&D, and ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs